Cargando…
Human Endogenous Retroviruses in Glioblastoma Multiforme
Glioblastoma multiforme (GBM) is the most aggressive and deadly brain tumor. It is primarily diagnosed in the elderly and has a 5-year survival rate of less than 6% even with the most aggressive therapies. The lack of biomarkers has made the development of immunotherapy for GBM challenging. Human en...
Autores principales: | Yuan, Zihao, Yang, Yuntao, Zhang, Ningyan, Soto, Claudio, Jiang, Xiaoqian, An, Zhiqiang, Zheng, Wenjin Jim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067472/ https://www.ncbi.nlm.nih.gov/pubmed/33917421 http://dx.doi.org/10.3390/microorganisms9040764 |
Ejemplares similares
-
The potential role of human endogenous retrovirus K in glioblastoma
por: Hothi, Parvinder, et al.
Publicado: (2023) -
Current Immunotherapies for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2021) -
Drug target ranking for glioblastoma multiforme
por: Saraf, Radhika, et al.
Publicado: (2021) -
Human endogenous retrovirus K contributes to a stem cell niche in glioblastoma
por: Shah, Ashish H., et al.
Publicado: (2023) -
Human endogenous retroviruses and ageing
por: Hurme, Mikko, et al.
Publicado: (2021)